EconomySun Pharma profit falls on Organon deal charge, while specialty drug sales stay strong
India’s Sun Pharmaceutical Industries reported lower second-quarter profit on Friday, weighed by a one-time charge largely linked to its planned acquisition of Organon. Demand for specialty medicines remained strong.
R
Reuters★★☆☆☆2026-10-30 09:45Original
Sun Pharma profit falls on Organon deal charge, while specialty drug sales stay strong
Economy